Redmile Group, LLC's Net Worth

$47.8 Million

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is Redmile Group, LLC

Redmile Group, LLC has an estimated net worth of $47.8 Million. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, XERIS PHARMACEUTICALS INC, RayzeBio, Inc., Allakos Inc., Science 37 Holdings, Inc., PLIANT THERAPEUTICS, INC., Stoke Therapeutics, Inc., Absci Corp, Adagio Therapeutics, Inc., Gritstone Oncology, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Allovir, Inc., IGM Biosciences, Inc., Verve Therapeutics, Inc., Nurix Therapeutics, Inc., Akero Therapeutics, Inc., Replimune Group, Inc., AMICUS THERAPEUTICS INC, FATE THERAPEUTICS INC, Kymera Therapeutics, Inc., Beam Therapeutics Inc., Augmedix, Inc., Neoleukin Therapeutics, Inc., Syros Pharmaceuticals, Inc., Atreca, Inc., VAPOTHERM INC, Shattuck Labs, Inc., TCR2 THERAPEUTICS INC., HOOKIPA Pharma Inc., Cabaletta Bio, Inc., Annexon, Inc., MedAvail Holdings, Inc., Aprea Therapeutics, Inc., ARRAY BIOPHARMA INC, Zymeworks Inc., and ADC Therapeutics SA.

SEC CIK

Redmile Group, LLC's CIK is 0001425738

Past Insider Trading and Trends

2024 was Redmile Group, LLC's most active year for acquiring shares with 20 total transactions. Redmile Group, LLC's most active month to acquire stocks was the month of December. 2016 was Redmile Group, LLC's most active year for disposing of shares, totalling 5 transactions. Redmile Group, LLC's most active month to dispose stocks was the month of June. 2024 saw Redmile Group, LLC paying a total of $30,511,754.97 for 8,297,647 shares, this is the most they've acquired in one year. In 2023 Redmile Group, LLC cashed out on 5,000,000 shares for a total of $15,000,000.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALDER BIOPHARMACEUTICALS INC

Investor

Updated Oct 24, 2019


Form 4	-98.96%	-9.09M	—	—	Oct 24, 2019	95.24K	Options	—	Oct 22
Form 4	2.50%	19.02K	$137.85	$2.62M	Jul 01, 2019	779.78K	Grant	—	Jun 30
Form 4	—	22.50K	—	—	May 24, 2019	22.50K	Grant	—	May 23
Form 4	26.73%	1.74M	$11.50	$20.00M	Mar 06, 2019	8.24M	Grant	—	Mar 04
Form 4	2.50%	18.56K	$137.86	$2.56M	Jan 03, 2019	760.75K	Acquisition	—	Dec 31
Form 4	2.33%	16.93K	$137.85	$2.33M	Jul 18, 2018	742.20K	Acquisition	—	Jun 30
Form 4	—	15.00K	—	—	May 25, 2018	15.00K	Grant	—	May 23
Form 4	—	30.00K	—	—	Apr 26, 2018	30.00K	Grant	—	Apr 25
Form 3	—	—	—	—	Apr 26, 2018	6.51M	—	—	—

Showing 9 results

XERIS PHARMACEUTICALS INC

Investor

Updated Feb 21, 2019


Form 4	24.37%	588.00K	$10.00	$5.88M	Feb 21, 2019	3.00M	Purchase	—	Feb 19
Form 4	-22.42%	-697.15K	$15.00	—	Jun 27, 2018	2.41M	Buy-Options	—	Jun 25
Form 3	—	—	—	—	Jun 20, 2018	—	—	—	—

Showing 3 results

RayzeBio, Inc.

Investor

Updated Sep 21, 2023


Form 4	3.48%	62.43K	—	—	Sep 21, 2023	1.86M	Options	—	Sep 19
Form 3	—	—	—	—	Sep 14, 2023	—	—	—	—


Form 4	-20.00%	-252.28K	—	—	Jul 24, 2018	1.01M	Options	—	Jul 23
Form 3	—	—	—	—	Jul 18, 2018	—	—	—	—


Form 4	-100.00%	-1.12M	$5.75	-$5.85M	Mar 13, 2024	—	Disposition	—	Mar 12
Form 4	2.49%	494.85K	$0.25	$125.00K	May 15, 2023	20.34M	Grant	—	May 11
Form 4	—	—	$3.38	—	Jun 15, 2022	39.70M	Acq/Dis	—	Jun 13
Form 4	0.21%	40.98K	$3.05	$125.00K	May 25, 2022	19.85M	Grant	—	May 23
Form 4/A	296.16%	14.81M	—	—	Oct 18, 2021	19.81M	Grant	—	Oct 06
Form 4	—	41.36K	—	—	Oct 12, 2021	41.36K	Grant	—	Oct 07
Form 4	295.02%	14.75M	—	—	Oct 08, 2021	21.67M	Grant	—	Oct 06
Form 3	—	—	—	—	Oct 08, 2021	5.00M	—	—	—


Form 4	-86.01%	-11.75M	—	—	Jun 09, 2020	1.91M	Options	—	Jun 05
Form 3	—	—	—	—	Jun 02, 2020	—	—	—	—


Form 4	—	—	—	—	Jun 24, 2019	671.81K	Options	—	Jun 21
Form 3	—	—	—	—	Jun 18, 2019	—	—	—	—


Form 4	0.55%	45.09K	—	—	Jun 14, 2024	8.30M	Grant	—	Jun 12
Form 4	2.77%	222.22K	$4.50	$1.00M	Mar 05, 2024	8.25M	Purchase	—	Mar 01
Form 4	—	53.10K	—	—	Jun 16, 2023	53.10K	Grant	—	Jun 14
Form 4	—	28.70K	—	—	Jun 10, 2022	28.70K	Grant	—	Jun 08
Form 4	30.46%	1.88M	$16.00	—	Jul 28, 2021	8.03M	Purchase	—	Jul 26
Form 3	—	—	—	—	Jul 21, 2021	—	—	—	—


Form 4	76.52%	1.47M	$17.00	—	Aug 12, 2021	3.39M	Purchase	—	Aug 10
Form 3	—	—	—	—	Aug 05, 2021	—	—	—	—


Form 4	—	—	—	—	Oct 03, 2018	1.39M	Options	—	Oct 02
Form 3	—	—	—	—	Sep 27, 2018	—	—	—	—


Form 4	104.78%	1.00M	$20.00	—	Nov 04, 2021	1.95M	Purchase	—	Nov 02
Form 3	—	—	—	—	Oct 28, 2021	—	—	—	—


Form 4	—	—	—	—	Jun 25, 2020	1.59M	Options	—	Jun 23
Form 3	—	—	—	—	Jun 19, 2020	—	—	—	—


Form 4	-32.90%	-403.62K	—	—	Aug 05, 2020	823.37K	Options	—	Aug 03
Form 3	—	—	—	—	Jul 30, 2020	—	—	—	—


Form 4	0.06%	1.73K	—	—	Jul 02, 2024	3.08M	Grant	—	Jun 28
Form 4	-0.35%	-10.73K	—	—	Apr 01, 2024	3.08M	Disposition	—	Mar 28 - Mar 29
Form 4	—	29.40K	—	—	Mar 14, 2024	29.40K	Grant	—	Mar 12
Form 4	—	—	—	—	Mar 01, 2024	10.29M	Options	—	Feb 28
Form 4	0.02%	492.00	—	—	Jan 03, 2024	2.98M	Grant	—	Dec 29
Form 4	0.02%	492.00	—	—	Oct 03, 2023	2.98M	Grant	—	Sep 29
Form 4	0.02%	492.00	$9.42	—	Jul 03, 2023	5.95M	Purchase	—	Jun 29 - Jun 30
Form 4	62.50%	2.81M	$8.00	$22.50M	Jun 28, 2023	7.31M	Grant	—	Jun 26
Form 4	—	15.50K	—	—	Apr 06, 2023	15.50K	Grant	—	Apr 04
Form 4	0.01%	492.00	—	—	Apr 04, 2023	3.34M	Grant	—	Mar 31
Form 4	0.01%	230.00	—	—	Jan 04, 2023	3.34M	Grant	—	Dec 30
Form 4	—	—	$22.49	—	Oct 05, 2022	17.01M	Acq/Dis	—	Oct 03
Form 4	0.01%	230.00	—	—	Oct 04, 2022	3.34M	Grant	—	Sep 30
Form 4	0.01%	230.00	—	—	Jul 05, 2022	3.34M	Grant	—	Jun 30
Form 4	49.91%	2.61M	$23.00	$60.00M	Apr 04, 2022	7.84M	Purchase	—	Mar 31 - Apr 01
Form 4	—	29.50K	—	—	Mar 15, 2022	29.50K	Grant	—	Mar 12
Form 4	0.00%	130.00	—	—	Jan 04, 2022	3.34M	Grant	—	Dec 31
Form 4	0.00%	130.00	—	—	Oct 04, 2021	3.43M	Grant	—	Sep 30
Form 4	0.00%	130.00	—	—	Jul 02, 2021	3.43M	Grant	—	Jun 30
Form 4	0.00%	130.00	—	—	Apr 02, 2021	3.43M	Grant	—	Mar 31
Form 4	—	6.42K	—	—	Feb 23, 2021	6.42K	Grant	—	Feb 19
Form 4	0.01%	178.00	—	—	Jan 05, 2021	3.43M	Grant	—	Dec 31
Form 4	—	667.67K	$89.99	$60.08M	Dec 15, 2020	667.67K	Purchase	—	Dec 11
Form 4	0.01%	178.00	—	—	Oct 05, 2020	3.43M	Grant	—	Oct 01
Form 4	4.41%	144.81K	$50.52	$7.32M	Sep 09, 2020	3.43M	Purchase	—	Sep 04 - Sep 09
Form 4	4.35%	136.65K	$47.21	$6.45M	Sep 03, 2020	3.28M	Purchase	—	Sep 01 - Sep 03
Form 4	0.01%	178.00	—	—	Jul 06, 2020	3.14M	Grant	—	Jul 01
Form 4	0.32%	10.18K	—	—	Apr 03, 2020	3.15M	Grant	—	Feb 05 - Apr 01
Form 4	166.21%	3.14M	$16.00	$50.30M	Sep 23, 2019	5.04M	Options	—	Sep 20
Form 4	—	12.10K	—	—	Sep 19, 2019	12.10K	Grant	—	Sep 17
Form 3	—	—	—	—	Sep 17, 2019	—	—	—	—


Form 4	-76.41%	-6.27M	$19.00	—	Jun 23, 2021	1.94M	Buy-Options	—	Jun 21
Form 3	—	—	—	—	Jun 16, 2021	—	—	—	—


Form 4	—	—	—	—	Jul 30, 2020	1.18M	Options	—	Jul 28
Form 3	—	—	—	—	Jul 23, 2020	—	—	—	—


Form 4	-67.47%	-1.54M	—	—	Jun 24, 2019	743.80K	Options	—	Jun 24
Form 3	—	—	—	—	Jun 19, 2019	—	—	—	—


Form 4	894.69%	701.27K	—	—	Jul 25, 2018	779.66K	Options	—	Jul 24
Form 3	—	—	—	—	Jul 19, 2018	—	—	—	—


Form 4	0.51%	66.30K	$7.20	$477.36K	Jun 13, 2016	12.96M	Purchase	—	Jun 03
Form 3	—	—	—	—	Jun 13, 2016	12.89M	—	—	—


Form 4	—	40.00K	—	—	Jun 11, 2024	40.00K	Grant	—	Jun 07
Form 4	1,413.22%	3.64M	$5.50	$20.00M	Mar 25, 2024	3.89M	Grant	—	Mar 21
Form 4	0.17%	44.63K	$3.72	$166.02K	Dec 28, 2023	26.32M	Purchase	—	Dec 26
Form 4	—	40.00K	—	—	Jun 08, 2023	40.00K	Grant	—	Jun 06
Form 4	2.15%	276.64K	$6.17	$1.71M	Apr 21, 2023	13.14M	Purchase	—	Apr 20 - Apr 21
Form 4	-0.29%	-142.88K	$9.74	-$1.61M	Apr 17, 2023	48.44M	Sale	—	Apr 13 - Apr 14
Form 4	0.16%	20.54K	—	—	Jun 13, 2022	12.98M	Grant	—	Jun 09
Form 4	0.05%	7.01K	—	—	Jun 04, 2021	12.96M	Grant	—	Jun 02
Form 4	4.63%	584.79K	$85.50	$50.00M	Jan 12, 2021	13.21M	Purchase	—	Jan 08
Form 4	12.60%	1.41M	$28.31	$40.00M	Jun 17, 2020	12.63M	Purchase	—	Jun 11
Form 4	—	16.00K	—	—	May 05, 2020	16.00K	Grant	—	May 01
Form 4	8.27%	857.14K	$17.50	$15.00M	Sep 17, 2019	11.22M	Purchase	—	Sep 16
Form 4	-0.89%	-25.00K	—	—	Aug 02, 2019	2.79M	Disposition	—	Jul 31
Form 4	—	16.00K	—	—	May 06, 2019	16.00K	Grant	—	May 03
Form 4	55.64%	3.70M	$13.50	$50.00M	Sep 27, 2018	10.36M	Purchase	—	Sep 25
Form 4	—	24.00K	—	—	Aug 02, 2018	24.00K	Grant	—	Jul 31
Form 3	—	—	—	—	Aug 02, 2018	6.66M	—	—	—
Form 3	—	—	—	—	Dec 19, 2017	6.66M	—	—	—


Form 4	-37.30%	-970.08K	—	—	Aug 25, 2020	1.63M	Options	—	Aug 25
Form 3	—	—	—	—	Aug 20, 2020	—	—	—	—


Form 4	-77.70%	-4.05M	—	—	Feb 11, 2020	1.16M	Options	—	Feb 10
Form 3	—	—	—	—	Feb 05, 2020	—	—	—	—


Form 4	0.08%	12.88K	—	—	Jun 18, 2024	16.42M	Grant	—	Jun 14
Form 4	0.02%	3.13K	—	—	Mar 19, 2024	16.41M	Grant	—	Mar 15
Form 4	0.01%	1.77K	—	—	Dec 19, 2023	16.41M	Grant	—	Dec 15
Form 4	15.14%	3.69M	$4.00	$6.00M	Nov 22, 2023	28.04M	Purchase	—	Nov 20
Form 4	0.01%	2.09K	$4.78	$10.00K	Sep 05, 2023	15.65M	Grant	—	Aug 31
Form 4	0.14%	21.60K	—	—	Jul 17, 2023	15.65M	Grant	—	Jul 13
Form 4	-13.79%	-5.00M	$3.00	-$15.00M	May 04, 2023	31.26M	Disposition	—	May 02
Form 4/A	35.38%	1.63M	$4.00	$6.50M	Apr 21, 2023	6.22M	Purchase	—	Oct 28
Form 4	30.42%	4.38M	$1.60	$7.00M	Apr 21, 2023	18.76M	Grant	—	Apr 19
Form 4	12.74%	1.63M	$4.00	$6.50M	Nov 01, 2021	14.38M	Purchase	—	Oct 28
Form 4	64.47%	5.00M	$3.00	$15.00M	Oct 07, 2020	12.76M	Purchase	—	Oct 05
Form 3	—	—	—	—	Oct 07, 2020	7.76M	—	—	—


Form 4	4.52%	174.63K	$10.77	$1.79M	Apr 06, 2020	4.04M	Purchase	—	Mar 27 - Apr 02
Form 3	—	—	—	—	Apr 06, 2020	3.87M	—	—	—


Form 4	-39.88%	-849.27K	$12.50	$5.41M	Jul 07, 2016	1.28M	Buy-Options	—	Jul 06
Form 3	—	—	—	—	Jun 29, 2016	—	—	—	—


Form 4	—	—	—	—	Jun 24, 2019	715.31K	Options	—	Jun 24
Form 3	—	—	—	—	Jun 19, 2019	—	—	—	—


Form 4	-92.73%	-12.23M	—	—	Nov 16, 2018	959.54K	Options	—	Nov 16
Form 3	—	—	—	—	Nov 13, 2018	—	—	—	—


Form 4	—	27.70K	—	—	Jun 21, 2024	27.70K	Grant	—	Jun 21
Form 4	-0.08%	-4.42K	—	—	Apr 01, 2024	5.62M	Disposition	—	Mar 28
Form 4	—	3.10M	—	—	Dec 26, 2023	3.10M	Grant	—	Dec 21
Form 4	—	40.26K	—	—	May 31, 2023	40.26K	Grant	—	May 26
Form 4	—	40.26K	—	—	Jun 10, 2022	40.26K	Grant	—	Jun 08
Form 4	—	3.43K	—	—	Jun 22, 2021	3.43K	Grant	—	Jun 19
Form 4	—	1.29K	—	—	Dec 28, 2020	1.29K	Grant	—	Dec 22
Form 4	1,666.91%	5.30M	$17.34	—	Oct 15, 2020	5.62M	Purchase	—	Oct 14
Form 3	—	—	—	—	Oct 08, 2020	—	—	—	—


Form 4	-83.85%	-4.19M	—	—	Feb 21, 2019	807.26K	Options	—	Feb 19
Form 3	—	—	—	—	Feb 13, 2019	—	—	—	—


Form 4	1,064.30%	913.49K	—	—	Apr 24, 2019	999.32K	Options	—	Apr 23
Form 3	—	—	—	—	Apr 17, 2019	—	—	—	—


Form 4	-33.33%	-348.19K	—	—	Oct 29, 2019	696.38K	Options	—	Oct 29
Form 3	—	—	—	—	Oct 24, 2019	—	—	—	—


Form 4	-88.65%	-12.47M	—	—	Jul 30, 2020	1.60M	Options	—	Jul 28
Form 3	—	—	—	—	Jul 23, 2020	—	—	—	—